[1]
Hussein Hazim Saleh et al. 2025. Therapeutic Drug Monitoring of Infliximab in Iraqi Patients with Moderate to Severe Ulcerative Colitis. Iraqi Journal of Pharmaceutical Sciences . 34, 3 (Sep. 2025), 90–99. DOI:https://doi.org/10.31351/vol34iss3pp90-99.